These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9553954)

  • 1. Interaction of phentermine plus fenfluramine: neurochemical and neurotoxic effects.
    Halladay AK; Fisher H; Wagner GC
    Neurotoxicology; 1998 Apr; 19(2):177-83. PubMed ID: 9553954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotoxic effects of +/-fenfluramine and phenteramine, alone and in combination, on monoamine neurons in the mouse brain.
    McCann UD; Yuan J; Ricaurte GA
    Synapse; 1998 Nov; 30(3):239-46. PubMed ID: 9776127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined phentermine/fenfluramine administration enhances depletion of serotonin from central terminal fields.
    Lew R; Weisenberg B; Vosmer G; Seiden LS
    Synapse; 1997 May; 26(1):36-45. PubMed ID: 9097403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phentermine and fenfluramine. Preclinical studies in animal models of cocaine addiction.
    Rothman RB; Elmer GI; Shippenberg TS; Rea W; Baumann MH
    Ann N Y Acad Sci; 1998 May; 844():59-74. PubMed ID: 9668665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of antihistamines on fenfluramine-induced depletion of indoles in the brain of rats.
    Yeh SY
    Synapse; 1999 Jun; 32(4):301-11. PubMed ID: 10332805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of repeated fenfluramine administration on indices of monoamine function in rat brain: pharmacokinetic, dose response, regional specificity and time course data.
    Zaczek R; Battaglia G; Culp S; Appel NM; Contrera JF; De Souza EB
    J Pharmacol Exp Ther; 1990 Apr; 253(1):104-12. PubMed ID: 2329498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind clinical trial in weight control. Use of fenfluramine and phentermine alone and in combination.
    Weintraub M; Hasday JD; Mushlin AI; Lockwood DH
    Arch Intern Med; 1984 Jun; 144(6):1143-8. PubMed ID: 6375610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ascorbic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5-HT.
    Shankaran M; Yamamoto BK; Gudelsky GA
    Synapse; 2001 Apr; 40(1):55-64. PubMed ID: 11170222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined dopamine and serotonin agonists: a synergistic approach to alcoholism and other addictive behaviors.
    Hitzig P
    Md Med J; 1993 Feb; 42(2):153-6. PubMed ID: 8097012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose fenfluramine administration decreases serotonin transporter binding, but not serotonin transporter protein levels, in rat forebrain.
    Rothman RB; Jayanthi S; Wang X; Dersch CM; Cadet JL; Prisinzano T; Rice KC; Baumann MH
    Synapse; 2003 Dec; 50(3):233-9. PubMed ID: 14515341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of subchronic exposure to styrene on the extracellular and tissue levels of dopamine, serotonin and their metabolites in rat brain.
    Gagnaire F; Chalansonnet M; Carabin N; Micillino JC
    Arch Toxicol; 2006 Oct; 80(10):703-12. PubMed ID: 16518643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoxetine increases the anorectic and long-term dopamine-depleting effects of phentermine.
    Callahan BT; Yuan J; Ricaurte GA
    Synapse; 2000 Dec; 38(4):471-6. PubMed ID: 11044894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of phentermine and cocaine on fenfluramine-induced depletion of serotonin in mouse brain.
    Baumann MH; Schuster CR; Rothman RB
    Drug Alcohol Depend; 1996 May; 41(1):71-4. PubMed ID: 8793312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of depletion of brain serotonin by repeated fenfluramine on neurochemical and anorectic effects of acute fenfluramine.
    Kleven MS; Schuster CR; Seiden LS
    J Pharmacol Exp Ther; 1988 Sep; 246(3):822-8. PubMed ID: 2458447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-tert-butyl-alpha-phenylnitrone protects against 3,4-methylenedioxymethamphetamine-induced depletion of serotonin in rats.
    Yeh SY
    Synapse; 1999 Mar; 31(3):169-77. PubMed ID: 10029234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of phentermine and fenfluramine on alcohol consumption and alcohol withdrawal seizures in rats.
    Halladay AK; Fisher H; Wagner GC
    Alcohol; 2000 Jan; 20(1):19-29. PubMed ID: 10680713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methamphetamine and human immunodeficiency virus protein Tat synergize to destroy dopaminergic terminals in the rat striatum.
    Theodore S; Cass WA; Maragos WF
    Neuroscience; 2006 Feb; 137(3):925-35. PubMed ID: 16338084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotoxic regimen of methamphetamine produces evidence of behavioral sensitization in the rat.
    Wallace TL; Gudelsky GA; Vorhees CV
    Synapse; 2001 Jan; 39(1):1-7. PubMed ID: 11071703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
    McNamara R; Kerans A; O'Neill B; Harkin A
    Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones.
    Sanchez V; O'shea E; Saadat KS; Elliott JM; Colado MI; Green AR
    J Psychopharmacol; 2004 Sep; 18(3):412-6. PubMed ID: 15358986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.